METHOD OF TREATING PROLIFERATIVE DIABETIC RETINOPATHY COMPLICATED BY HAEMOPHTHALMIA WITH USING INTRAOPERATIVE FLUORESCEIN ANGIOGRAPHY Russian patent published in 2015 - IPC A61F9/08 

FIELD: medicine.

SUBSTANCE: method involves a vitrectomy, a detachment and a removal of a posterior hyaloids of a vitreous body, and a retinal laser endocoagulation. After transparency of the vitreal cavity structures is recovered, a fluorescein angiography (FAG) is performed. If the FAG findings enable visualising hyperfluorescence close to a vascular arcade and a macular area, the retinal laser endocoagulation is performed in this area at wave length 532 nm, pulse length 0.1 s, spot diameter 100 mcm, power 70-100 mWt, in a number of 100-200 coagulates. If the hyperfluorescence is found to be outside the vascular arcades, then the retinal laser endocoagulation is performed in this area at wave length 532 nm, pulse length 0.2 s, spot diameter 200-400 mcm, power 150-250 mWt, in a number of 400-500 coagulates.

EFFECT: reducing the amount of total laser energy that enables reducing complications, such as recurrent haemophthalmia, progressive proliferation, developing retinal detachment.

4 ex